COMPASS Pathways Plc American Depository Shares closed at $9.12 on Nov 12, down 1.94%, 40.0% below its 52-week closing high. Volume of 2.4M shares was 0.62× its 20-day average (below normal).
Split-adjusted performance: -19.1% over one month, -14.1% over six months, +60.0% over one year.
Short interest was 17.2M shares at the Oct 30 settlement, down 2.7% from the prior report (7.7 days to cover).
No reported quarters with price history yet.
Percentile among 417 companies (100 = best)
Industry medians: 6-month return −26.3%, revenue growth +9.3%, net margin −35.1%, P/E 16.5×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| CMPSCOMPASS Pathways Plc American Depository Shares | $9.12 | −1.94% | −14.1% | — | — | — | $1.29B | |
| SLNSilence Therapeutics Plc American Depository Share | $19.80 | +0.15% | +177.7% | — | — | — | $1.23B | Compare |
| GPCRStructure Therapeutics | $19.84 | −5.30% | −50.2% | — | — | — | $1.41B | Compare |
| ZLABZai Lab Limited | $26.04 | −1.44% | +28.1% | −6.8% | −42.6% | — | $3.22B | Compare |
| AMRNAmarin | $11.67 | −0.34% | −21.0% | −20.4% | 0.6% | — | $490.6M | Compare |
| BCYCBicycle Therapeutics | $3.45 | −6.50% | −26.1% | +190.2% | −30.8% | — | $241.8M | Compare |
| KZIAKazia Therapeutics Limited | $6.95 | −6.46% | −49.7% | — | — | — | $108.1M | Compare |
| MREOMereo BioPharma Group | $0.3050 | −0.52% | +24.0% | — | — | — | $48.7M | Compare |
| ONCBeOne Medicines | $415.96 | −0.96% | +36.6% | +33.8% | 20.4% | 51.9 | $47.51B | Compare |
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
